MedTrace Logo

The Relationship Between Cadaveric Allograft Skin and HLA-Sensitivity in Burn Patients

NCT04162639 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-03-19

No results posted yet for this study

Summary

The purpose of this research study is to look at how the body's immune system reacts to temporary skin grafts from deceased donors.

Conditions

  • Burns

Interventions

BIOLOGICAL

Skin allograft

Participants will receive skin allograft from either 1, 2 or 3 distinct cadavers. This skin allograft will be applied in a routine fashion, with no deviation from the typical clinical course of treatment.

Sponsors & Collaborators

  • AlloSource

    collaborator INDUSTRY

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Michael Feldman · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-28
Primary Completion
2023-02-28
Completion
2023-02-28
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04162639 on ClinicalTrials.gov